Aurobindo pharma partners with Sandoz for acquiring over its buisness
- Country:
- India
Aurobindo pharma inks pact with Sandoz for acquiring its dermatology and oral solids business for USD 900 million.
Aurobindo pharma inks pact with Sandoz for acquiring its dermatology and oral solids business for USD 900 million.
Google News
RSS
Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.
By submitting, you agree that we may use your email address to respond.
